Venture Management Co. V, L... Net Worth

The estimated Net Worth of Venture Management Co. V, L... is at least $30.4 Millón dollars as of 15 July 2019. Venture L owns over 68,727 units of Cardlytics Inc stock worth over $70,179 and over the last 11 years Venture sold CDLX stock worth over $30,337,414.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Venture L CDLX stock SEC Form 4 insiders trading

Venture has made over 16 trades of the Cardlytics Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Venture sold 68,727 units of CDLX stock worth $1,900,989 on 15 July 2019.

The largest trade Venture's ever made was buying 833,333 units of Cardlytics Inc stock on 4 October 2013 worth over $4,999,998. On average, Venture trades about 143,553 units every 124 days since 2013. As of 15 July 2019 Venture still owns at least 21,331 units of Cardlytics Inc stock.

You can see the complete history of Venture L stock trades at the bottom of the page.

Insiders trading at Cardlytics Inc

Over the last 7 years, insiders at Cardlytics Inc have traded over $241,564,482 worth of Cardlytics Inc stock and bought 4,370,284 units worth $182,244,506 . The most active insiders traders include Clifford Sosin, Viii Lp Canaan Partners Vii... y Venture Management Co. V, L.... On average, Cardlytics Inc executives and independent directors trade stock every 5 days with the average trade being worth of $100,378. The most recent stock trade was executed by Scott A Hill on 5 September 2024, trading 6,748 units of CDLX stock currently worth $22,201.

What does Cardlytics Inc do?

cardlytics uses purchase-based intelligence to make marketing more relevant and measurable. we partner with more than 2,000 financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. in turn, we have a secure view into where and when consumers are spending their money. we use these insights to help marketers identify, reach and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. at cardlytics, we are analysts, developers, and data scientists. we are marketers, account managers, and consultants to our clients. we are all focused on making sense of the data we see to make it informative and actionable for our partners. headquartered in atlanta, ga, with offices in new york city, london, san francisco, and chicago, our team rallies around a common desire to win and to help our clients win. we are focused on building a revolutionizing company, but we still care about each other

Complete history of Venture L stock trades at Fate Therapeutics Inc, Genocea Biosciences Inc, Ocular Therapeutix Inc, Selecta Biosciences Inc y Cardlytics Inc

Cardlytics Inc executives and stock owners

Cardlytics Inc executives and other stock owners filed with the SEC include:

• Scott Grimes,
  Executive Chairman of the Board
• Lynne Laube,
  Chief Executive Officer, Co-Founder, Director
• Lynne Marie Laube,
  Co-Founder, CEO & Director
• Kirk L. Somers,
  Chief Legal & Privacy Officer and Sec.
• David Adams,
  Independent Director
• Andrew C. Christiansen,
  Chief Financial Officer
• Scott D. Grimes,
  Co-Founder & Exec. Chairman
• John Klinck,
  Independent Director
• Tony Weisman,
  Independent Director
• John Balen,
  Lead Independent Director
• Mark Johnson,
  Independent Director
• S Lapic,
  Independent Director
• Jessica Jensen,
  Director
• Andrew Christiansen,
  Chief Financial Officer
• Kirk Somers,
  Chief Legal and People Officer
• Peter Gleason,
  Pres of International Operations
• Ross McNab,
  Pres of North America Advter.
• Michael Akkerman,
  Chief Product & Strategy Officer
• Jared Luskin,
  Sr. VP of Growth Verticals
• Craig Snodgrass,
  Chief Data Officer
• Peter Davies,
  Head of Sales Strategy & Operations
• Peter Chan,
  Chief Technology Officer
• Of America Corp /De/Banc Of...,
  
• Viii Lp Canaan Partners Vii...,
  
• Venture Management Co. V, L...,
  
• Inc.Aeroplan Holdings Europ...,
  
• David Thomas Evans,
  Chief Administrative Officer
• Alexis De Sieno,
  Chief Financial Officer
• Venture Management Co. V, L...,
  
• Jonathan Edward Francis,
  Director
• Andre J Fernandez,
  Director
• Clifford Sosin,
  10% owner
• Bryce Youngren,
  Director
• Scott A Hill,
  Director
• Chris Suh,
  Director
• Karim Saad Temsamani,
  Chief Executive Officer
• Nicholas Hollmeyer Lynton,
  Chief Legal & Privacy Officer
• Amit Gupta,
  Chief Executive Officer
• Liane Hornsey,
  Director